136 results on '"Hui, Vicki Wing‐Ki"'
Search Results
2. Diabetes Mellitus Impacts on the Performance of Hepatocellular Carcinoma Risk Scores in Chronic Hepatitis B Patients
3. Baveno VII criteria for recompensation predict transplant-free survival in patients with hepatitis B-related decompensated cirrhosis
4. Drug–drug interactions between direct-acting antivirals and co-medications: a territory-wide cohort study
5. Risk of HCC in Patients with HBV, Role of Antiviral Treatment
6. Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss
7. Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir
8. FRI-387 Similarly low risk of hepatocellular carcinoma and cirrhotic complications in patients in the HBeAg-negative indeterminate phase compared with chronic infection
9. SAT-292 Coinfection with viral hepatitis increases the short-term but not the long-term risks of hepatocellular carcinoma and hepatic events in adults with alcohol-related cirrhosis
10. Hepatocellular carcinoma surveillance after HBsAg seroclearance
11. Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis
12. Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
13. Letter: Rethinking the lower incidence of HCC in HIV‐infected patients—A closer look at confounding factors. Authors' reply
14. Similarly low risk of chronic kidney disease (CKD) progression in chronic hepatitis B patients with Stage 2 CKD on tenofovir alafenamide versus entecavir
15. Secular trends of newly diagnosed chronic hepatitis B in 2000–2022-a territory-wide study
16. HBsAg seroclearance decreases risk of hepatocellular carcinoma but not hepatic decompensation in nucleos (t)ide analogue-treated cirrhotic patients with complete hepatitis B virus suppression: a territory-wide cohort study
17. Switching to peginterferon for chronic hepatitis B patients with hepatitis B e antigen seroconversion on entecavir-a long term follow-up study
18. Predictors of Baveno VII criteria for recompensation in patients with hepatitis B-related decompensated cirrhosis
19. Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysis
20. Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection.
21. Trends in risk factor control and treatment among patients with non‐alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory‐wide study
22. Letter: vaccination for global control of hepatitis B—from prevention to elimination. Authorsʼ reply
23. IDDF2022-ABS-0226 Long-term risk of hepatocellular carcinoma and hepatic decompensation after hepatitis B surface antigen seroclearance: a territory-wide cohort of 9,769 patients
24. Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma
25. Age and the relative importance of liver‐related deaths in nonalcoholic fatty liver disease
26. Three COVID-19 medications-remdesivir, molnupiravir and ritonavir-boosted nirmatrelvir-and serial liver biochemistries in 22, 456 subjects
27. Young-onset diabetes mellitus increases the risk of liver-related events in patients with non-alcoholic fatty liver disease
28. Age and the relative importance of liver-related deaths in non-alcoholic fatty liver disease
29. Secular trend of the accuracy of hepatocellular carcinoma risk scores in treated chronic hepatitis B patients in 2005–2020: a territory-wide study of 48, 706 subjects
30. The discriminatory power of risk scores for hepatocellular carcinoma in treated chronic hepatitis B patients with and without diabetes: a territory-wide study of 48,706 subjects
31. Two different types of COVID-19 vaccines and serial liver biochemistries
32. Changes of enhanced liver fibrosis score predict hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral treatment
33. Trends in risk factor control and treatment among patients with non-alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory-wide study.
34. Tenofovir alafenamide is associated with improved alanine aminotransferase and renal safety compared to tenofovir disoproxil fumarate
35. Risk of liver‐related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease
36. SAT-302 Long-term trends in the prevalence of alcohol-related cirrhosis among national U.S. veterans affairs data and territory wide Hong Kong data-an east-west perspective
37. Tu1384 RISK OF UPPER GASTROINTESTINAL BLEEDING IN DIRECT ORAL ANTICOAGULANT USERS: AN ASIAN POPULATION-BASED PROPENSITYSCORE ANALYSIS
38. Mo1519 LONG-TERM TRENDS IN RATES OF ALCOHOL ASSOCIATED HEPATITIS AMONG NATIONAL U.S. VETERANS AFFAIRS DATA AND TERRITORITY WIDE HONG KONG DATA: AN EAST-WEST PERSPECTIVE
39. Age and the relative importance of liver‐related deaths in nonalcoholic fatty liver disease.
40. Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver disease
41. Universal HBV Vaccination Dramatically Reduces Prevalence of HBV Infection and Incidence of Hepatocellular Carcinoma
42. Overview of methodologies and statistical strategies in observational studies and meta-analyses on the risk of hepatocellular carcinoma in patients with chronic hepatitis B on entecavir or tenofovir therapy
43. U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases
44. Association of metformin use on metabolic acidosis in diabetic patients with chronic hepatitis B‐related cirrhosis and renal impairment
45. Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B
46. Sodium‐glucose co‐transporter 2 inhibitors reduce hepatic events in diabetic patients with chronic hepatitis B
47. Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID‐19
48. Reply
49. Colonoscopy and Risk of Colorectal Cancer in Patients With Nonalcoholic Fatty Liver Disease: A Retrospective Territory‐Wide Cohort Study
50. Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.